The Ohio state Senate passed a bill earlier this week that will allow patients to force hospitals to administer drugs for off-label use. The passage of the bill comes after a years-long effort by ...
Evidence suggests commercial health plans are more likely to delay specialty drug coverage decisions in response to FDA ...
A patient in an open label extension study of Pfizer’s hemophilia treatment Hympavzi has died, the company and several hemophilia advocacy groups confirmed this week. Pfizer is now working with its ...
TORONTO--(BUSINESS WIRE)-- Satellos Bioscience Inc. (MSCL:CA) (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results